Related by context. All words. (Click for frequent words.) 64 SinuNase ™ 64 DPX Survivac 64 Fludara ® 63 Troxatyl TM 63 PHASE III 63 cathepsin K inhibitor 63 SUTENT ® 63 vapreotide acetate 63 Exherin 62 Fodosine 62 tramiprosate Alzhemed TM 62 phase Ib clinical 62 XL# anticancer compounds 62 histamine dihydrochloride 62 liposomal formulation 62 AAG geldanamycin analog 62 beta 1a 62 ocular formulation 62 anti CD3 monoclonal 62 selective immunoproteasome inhibitor 62 PDE4 inhibitor 62 pan histone deacetylase 62 VISICOL R 62 TLR9 agonist 61 P#X# antagonist 61 TRISENOX ® 61 selective estrogen receptor modulator 61 subcutaneous formulation 61 Phase Ib II 61 TPI ASM8 61 Initiates Phase II 61 reslizumab 61 Aurora kinase inhibitor 61 Panzem R 61 tiapamil 61 VitiGam 61 Personalized Immunotherapy 61 dextromethorphan quinidine 61 oral prodrug 61 LymphoStat B TM 61 Onconase 61 ABLYNX 61 Vaxfectin ® 61 Teysuno 61 mertansine 61 ALN PCS 61 hypoxia activated prodrug 61 Kosan dependence 61 JAK inhibitor 61 PANVAC VF 61 Surfaxin LS 61 IMA# 61 Vascular Wrap TM 60 orally administered inhibitor 60 PDX pralatrexate 60 Afatinib 60 GVAX ® 60 targeted antifolate 60 Shigamabs ® 60 RhuDex TM 60 Lovaza TM 60 Vascular Disrupting Agent 60 lexidronam injection 60 HDACi 60 PrevOnco ™ 60 oral picoplatin 60 HuMax TAC 60 targeted radiotherapeutic 60 Kiadis 60 Onalta ™ 60 CCR5 antagonist 60 investigational humanized monoclonal antibody 60 Spiegelmer ® 60 acyclovir Lauriad R 60 THR beta agonist 60 virus HCV protease inhibitor 60 elotuzumab 60 RELOVAIR ™ 60 BIM #A# 60 MOVIPREP R 60 mitogen activated ERK kinase 60 Phase IIb clinical trials 60 selective orally bioavailable 60 Fc fusion protein 60 miconazole Lauriad R 60 Urocidin 60 adecatumumab MT# 60 therapeutic monoclonal antibodies 60 docetaxel Taxotere R 60 IAP inhibitor 60 Polymer Microspheres 60 acetonide FA 60 multi kinase inhibitor 60 Pruvel 60 SPRYCEL ® 60 Zorbtive TM 60 Alzhemed TM 60 Myocet 60 phase IIa clinical 60 LymphoStat B belimumab 60 GLP1 INT TM 60 Phase Ib clinical trials 60 molecular imaging radiopharmaceutical 60 SPL# Gel vaginal microbicide 60 TLR9 agonists 59 FS Antihemophilic Factor Recombinant 59 Tezampanel 59 ALN HPN 59 humanized monoclonal 59 HuMax 59 Phase IIb III 59 histone deacetylase HDAC 59 Silodosin 59 Legacy Biotechnologies 59 IMC #B 59 HIV integrase inhibitor 59 Alkeran 59 IMP# 59 Dalbavancin 59 EndoTAG 59 Shigamabs 59 oral antiviral 59 non nucleoside inhibitor 59 Telatinib 59 histone deacetylase inhibitor 59 alvespimycin 59 NOVARTIS 59 oral salmon calcitonin 59 nitric oxide donating prostaglandin 59 immatics 59 Hexvix ® 59 Anidulafungin 59 MT#/MEDI-# 59 Cloretazine ® 59 Pafuramidine 59 ALVESCO ® 59 YONDELIS R 59 dose escalation clinical 59 Receives Orphan Drug Designation 59 intranasal formulation 59 RhuDex ® 59 immunotherapeutic vaccine 59 ProtAffin 59 LEUKINE 59 OTCBB PYTO 59 TELINTRA 59 OncoVex 59 Phase #b/#a clinical 59 Potelligent Technology 59 Phase 2b clinical trials 59 Pyridorin 59 anticancer compound 59 midstage trials 59 HuLuc# 59 dasatinib Sprycel ® 59 initiated Phase Ib 59 Aflibercept 59 Prodarsan R 59 Crucell PER.C6 59 R Saizen R 59 JZP 59 balsalazide tablet 59 CYT# potent vascular disrupting 59 NeuroSTAT ® 59 TBC# 59 cetuximab Erbitux R 59 highly selective endothelin 59 bevacizumab Avastin R 59 Troxatyl 59 Zenvia ™ 59 Velcade bortezomib 59 non nucleoside HCV 59 Tesmilifene 59 Japanese Encephalitis Vaccine 59 KRYSTEXXA TM pegloticase 59 PrevOnco 59 NPC 1C 59 Cethrin R 59 apricitabine ATC 59 YONDELIS 59 RIGScan ™ 58 Ketotransdel 58 Nexavar ® 58 Crofelemer budesonide foam 58 Annamycin 58 HDAC Inhibitor 58 Archexin 58 antibody fragment therapeutics 58 seliciclib CYC# 58 candidates Azedra TM 58 highly selective inhibitor 58 Phase Ib clinical 58 telomerase therapeutic 58 RNAi therapeutic targeting 58 gemcitabine Gemzar ® 58 Phase IIIb clinical 58 SAR# [002] 58 topoisomerase II inhibitor 58 oral taxane 58 generation purine nucleoside 58 volociximab 58 PF # [002] 58 PNP inhibitor 58 Panzem ® 58 staphylococcal vaccine 58 MyVax R 58 LHRH antagonists 58 BLP# Liposome Vaccine 58 novel therapeutic antibodies 58 agonistic human 58 TRX1 58 Shigamabs R 58 HGS# 58 Polyphor 58 Capsulution 58 HTRF 58 KSP inhibitor 58 ALN TTR# 58 PEG SN# 58 Germany FSE SCH 58 REMICADE infliximab 58 methylnaltrexone bromide 58 Liprotamase 58 TRACON Pharmaceuticals 58 investigational HCV polymerase 58 Valortim TM 58 ESTRASORB R 58 Anavex #-# 58 Eraxis 58 Xcytrin R 58 cutaneous T 58 humanized anti 58 ProMune 58 HQK 58 SYCREST 58 lorvotuzumab mertansine 58 Completes Patient Enrollment 58 Iluvien ® 58 oral ridaforolimus 58 phase IIb 58 selectin antagonist 58 Didronel 58 deforolimus 58 Tarmogen 58 PSN# [001] 58 Phusion Laboratories 58 COLAZAL R 58 Relieva 58 registrational 58 JAK1 58 Liposomal 58 PLAVIX ® 58 CD# CEA 58 histone deacetylase HDAC inhibitor 58 PHX# 58 Phase 1b clinical 58 peptidomimetic 58 PEGylated interferon 58 Crop BioScience 58 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 58 Ciclesonide 58 Rebif ® 58 JOULFERON 58 TLR8 agonist 58 OvaRex R 58 PI3K/Akt pathway inhibitor 58 initiate Phase IIb 58 Valtropin 58 FOLOTYN ® 58 successfully commercialize Iluvien 58 Soliris TM eculizumab 58 selective adenosine 57 candidate deforolimus 57 poly ethylene glycol PEG 57 miconazole Lauriad 57 Zybrestat 57 Aganocide ® 57 octreotide acetate 57 Fenoglide 57 zanolimumab 57 IV Busulfex 57 Alfacell proprietary ribonuclease 57 MEDAREX 57 Sphingomab TM 57 candidates bavituximab 57 confirmatory Phase III 57 triciribine phosphate monohydrate 57 kidney urologic 57 Zenpep 57 2 methoxyestradiol 57 atacicept 57 topical emulsion 57 small molecule thrombopoietin 57 Announces Tentative Approval 57 selective kinase inhibitor 57 Preclinical studies suggest 57 mTOR inhibitor 57 Junovan TM 57 Initiate Phase 57 Inhalation Aerosol 57 diarrhea predominant irritable 57 JAK2 inhibitor 57 ADP receptor antagonist 57 omacetaxine mepesuccinate 57 sNDAs 57 Nanobody R 57 CardioVascular BioTherapeutics 57 Lymphoseek ® 57 estradiol transdermal spray 57 alemtuzumab MS 57 phase IIb clinical 57 Initiate Clinical Trial 57 amrubicin 57 inhaled formulation 57 ospemifene 57 virosome 57 UPLYSO 57 Nanobody ® 57 proprietary polysaccharide 57 orally inhaled 57 Glybera 57 monoclonal antibody MAb 57 novel VDA molecule 57 AQ4N 57 sterile lidocaine patch 57 antibody MAb 57 CRMD# 57 Factor VIIa 57 synthetic siRNA 57 bardoxolone 57 mTOR mammalian target 57 MK #B 57 Creabilis Therapeutics 57 Nycomed GmbH 57 topical ophthalmic 57 Proquin XR 57 aurora kinase 57 TOCOSOL Paclitaxel 57 severe hypercholesterolemia 57 Alferon N 57 Novasome R 57 pancreatic enzyme replacement 57 Enhanze Technology 57 Fresenius Biotech 57 Aerosurf 57 TO AVOID PREGNANCY WHILE 57 Kahalalide F 57 oral proteasome inhibitor 57 Davanat 57 Bosutinib 57 IAP inhibitors 57 Trastuzumab DM1 57 Sandimmune 57 Initiates Enrollment 57 pharmacodynamic biomarkers 57 Tibotec BVBA 57 Luteinizing Hormone Releasing Hormone 57 ATL# [001] 57 Multiple Ascending Dose 57 Nasdaq VNDA 57 Prednisporin TM 57 Finacea 57 novel emulsion formulation 57 Safinamide 57 LibiGel ® 57 outlicensing 57 Ceplene TM 57 therapeutic peptide 57 biologic therapeutics 57 Therapeutic Competitors Companies 57 adult mesenchymal stem 57 CEQ# 57 IL# PE#QQR 57 XP# XP# 57 Actelion Pharmaceuticals Ltd 57 vaginally administered lidocaine 57 subsidiaries visit http:/www.apricusbio.com 57 Therapeutic Competitors companiesandmarkets.com adEgemonye 57 Addex Pharmaceuticals SWISS ADXN 57 OR ITS SUBSIDIARIES 57 product Fentanyl TAIFUN 57 romazarit 57 MKC# MKC# PP 57 Monoclonal antibody 57 BLA filing 57 Onco TCS 57 registrational studies 57 Phase 2a clinical trials 57 MKGAY 57 HCV protease inhibitor 57 Nasdaq PARD 57 iobenguane 57 co licensor KDL 57 novel histone deacetylase 57 hoFH 57 NS5b 57 Janus Kinase 57 RELEASE ACCORDING TO 57 Aloxi ® 57 Phase IIb trials 57 Meritage Pharma 57 Japanese Encephalitis vaccine 57 oral nucleoside analogue 57 OTC IPXL today 57 outlicensed 56 anticancer therapeutics 56 ghrelin antagonist 56 Oracea TM 56 triphendiol 56 myelofibrosis polycythemia vera 56 intravenous acetaminophen 56 sumatriptan injection 56 Regeneron Pharma 56 ONCASPAR 56 Phase 1a clinical 56 EVIZON ™ 56 Therapeutic Competitors Report 56 Ceflatonin 56 Therapeutic Vaccine 56 DNA intercalator 56 Newron Pharmaceuticals SpA 56 MAA submission 56 OncoVEX GM CSF 56 ENTOCORT EC 56 Micromet BiTE 56 defensin mimetic antibiotic 56 Hedgehog antagonist 56 DiLA2 56 investigational hepatitis C 56 treat male hypogonadism 56 Cetrorelix 56 Successfully Completes Phase 56 Phase Ib study 56 RECOTHROM R 56 ruxolitinib 56 topically applied SEPA 56 RSE Grundbesitz und Beteiligungs 56 Nanobody 56 5 HT3 antagonist 56 therapeutic monoclonal antibody 56 metaglidasen 56 epoetin zeta 56 Files IND 56 Neulasta ® 56 trastuzumab DM1 T DM1 56 Initiates Clinical 56 Omacetaxine 56 Soriatane 56 GLP toxicology studies 56 Hepatitis C HCV 56 Civacir 56 Veronate R 56 sumatriptan DosePro 56 phase IIa 56 Locteron ® 56 Interferon alpha 56 specific CCR9 antagonist 56 StaphVAX R 56 SAFLUTAN 56 Neupogen ® 56 Dabigatran etexilate 56 fusion enhancers 56 PRT# 56 OLpur TM H2H 56 DepoVax TM 56 small molecule tyrosine 56 ATHX 56 novel synthetic peptide 56 investigational oral hepatitis C 56 hypoxia selective 56 Antithrombin 56 NS5B polymerase 56 hyaluronidase enzyme 56 EGS# 56 Phase #/#a 56 Sumatriptan Succinate 56 ARIKACE ™ 56 Epiphany Biosciences 56 RH1 56 Dyloject TM 56 LE SN# 56 Iluvien TM 56 ONCONASE R 56 Lispro 56 patented Bioral 56 Biopartners 56 AERx iDMS 56 PEP# [003] 56 long acting muscarinic 56 Parathyroid Hormone 56 mucosal vaccines 56 Ceflatonin R 56 SYGNIS 56 Novolimus 56 Phase #b/#a 56 ITAX 56 Emezine 56 include Altastaph TM 56 Phase IIa clinical 56 Nasdaq PGNX today 56 IMiDs R 56 brand ciclesonide HFA 56 Eligard R 56 EOquin 56 liprotamase 56 Activity Assay 56 Daclizumab 56 Trobalt 56 recombinant FVIII 56 GTC NASDAQ GTCB 56 Atelvia 56 % uracil topical 56 ANTEGREN 56 Nasdaq CGEN 56 FDA APPROVES 56 herpetic keratitis 56 orally bioavailable mimics 56 Cloretazine R 56 Voraxaze 56 Glatiramer acetate 56 ZK EPO 56 Interferon beta 56 TKPHF 56 HSP# inhibitor 56 Enjuvia 56 epothilone 56 LEP ETU 56 anti botulism antibody 56 News Unternehmensnachrichten DGAP Adhoc 56 Removab 56 PSMA ADC 56 inhaled liposomal ciprofloxacin 56 PNT# 56 randomized controlled Phase 56 Aplidin 56 ChemGenex Pharmaceuticals Limited 56 Locked Nucleic Acid LNA 56 Solasia 56 eprotirome 56 PREOS 56 COMUNICADO DE 56 Pharmacokinetics PK 55 SCIB1 55 selective androgen receptor modulators 55 Nicotine Conjugate Vaccine 55 NerPharMa 55 sodium glucose transporter 55 Lenocta TM 55 glucokinase activator 55 PREOS R 55 Recombinant Human 55 Phase 2b clinical 55 Homspera ® 55 BeneFIX 55 Phase lll 55 REGiMMUNE 55 Files Investigational 55 Bicifadine 55 ALTROPANE R 55 MOVIPREP ® 55 Gendux 55 Aloxi R 55 Alligator Bioscience AB 55 Onalta 55 Prodarsan ® 55 5 HT2C serotonin 55 chimeric monoclonal antibody 55 non nucleoside 55 HCV RNA polymerase 55 Somatuline R Autogel R 55 ATL# [002] 55 NUEDEXTA ™ 55 adrenergic regulation 55 lipid nanoparticle 55 Cenomed 55 Biopharmaceuticals AG 55 T Pred 55 Alvesco ® 55 CAMPATH 55 Aurora kinase 55 Pivotal Phase III 55 CD4 monoclonal antibody 55 granulated mesalamine 55 accumulate preferentially 55 AzaSite Plus 55 Orphan Drug designations 55 oral Janus kinase 55 ALN TTR 55 HepeX B 55 Signature Diagnostics 55 Raptiva R 55 ® bortezomib 55 Esmya 55 recombinant biopharmaceutical 55 Tyzeka Sebivo 55 Marketing Authorisation Application 55 CORT # 55 Phase IIb Trial 55 Mg Uk 55 RECOTHROM ® 55 Saizen R 55 cell lymphoma CTCL 55 Angiocept 55 orally disintegrating tablet ODT 55 Intravenous Human 55 antibody MT# 55 Dermylex R 55 Oral Spray 55 VEGF inhibitor 55 pathophysiological effects 55 polysaccharide polymer 55 DNA methyltransferase inhibitors 55 Tazorac 55 NanoTab 55 Boniva ibandronate 55 TELINTRA R 55 Epothilone 55 Febuxostat 55 Campath ® 55 BEMA Granisetron 55 ZFP Therapeutics 55 Idera Pharmaceuticals 55 Tofacitinib 55 Zirgan 55 Vernakalant 55 Roche SIX RO 55 ProEthic Pharmaceuticals 55 Ganciclovir 55 Hsp# Inhibitor 55 CINTREDEKIN BESUDOTOX 55 Vaccinex 55 2 inhibitor CYT# 55 Somatuline R Depot 55 TKB# 55 Zavesca r 55 Degarelix 55 Septin9 biomarker 55 Imvamune 55 small molecule glucokinase 55 HuCAL GOLD R 55 Gastrotech 55 NASDAQ PGNX 55 nasal calcitonin product 55 OncoVEX 55 PharmaNova 55 TREANDA 55 HuCAL R 55 NB S# strontium malonate 55 tubulin inhibitor 55 StemEx R 55 OPi 55 Exelixis compounds 55 LHRH antagonist 55 Icatibant 55 small molecule chemotherapeutic 55 rxRNA 55 Meets Primary Endpoint 55 Gonal f R 55 Astellas Deutschland GmbH 55 Elvitegravir 55 faropenem 55 Phase 2a trial 55 A3 adenosine receptor 55 Orphan Drug status 55 interleukin IL -# 55 humanized antibody 55 INOmax 55 Loramyc R 55 novel prodrug 55 Inhalation Solution 55 granted Ortec 55 HuMax HepC TM 55 Gentamicin Surgical Implant 55 Nabi HB R 55 Adnectin 55 phase Ib 55 t2cure GmbH 55 Cleviprex TM clevidipine 55 Privigen 55 Fast Track Status 55 Qutenza TM 55 Vidofludimus 55 WILEX 55 DGAP Ad hoc 55 sulodexide 55 Anturol ® 55 Sanvar R 55 AEG# 55 vidofludimus 55 Cintredekin Besudotox 55 MT# MEDI 55 anti angiogenic agent 55 opioid bowel dysfunction 55 mesylate tablets approved 55 NOX E# 55 Vion Pharmaceuticals 55 selective modulator 55 antisense drug 55 elbion 55 GlycoPEG GCSF 55 PRECISE trial 55 Ocrelizumab 54 Augment TM 54 celgosivir 54 Kuvan sapropterin dihydrochloride 54 NEUPREX R 54 CRTX 54 Fentanyl TAIFUN R 54 Nitec Pharma 54 HP Acthar R 54 transfection reagents 54 ISENTRESS raltegravir 54 Receives Approvable Letter 54 dose escalation Phase 54 Mg Usa 54 motexafin gadolinium Injection 54 Nasdaq ENZN 54 CellMed 54 Zentaris GmbH 54 SPRIX ® 54 potently inhibit 54 rasagiline tablets 54 Frova ® 54 LEVADEX ™ 54 Oral NKTR 54 BAL# [002] 54 Poly ICLC 54 Phase Ib 54 forodesine hydrochloride 54 HCV polymerase 54 Phase III randomized controlled 54 XL# XL# XL# 54 Aurora Kinase 54 5 HT2A serotonin 54 proprietary intravenous formulation 54 Friedreich Ataxia FRDA 54 E1 INT TM 54 Cardio Vascu Grow 54 hematological cancers 54 Orathecin 54 BRILINTA 54 fusion inhibitor 54 Pivotal Phase 54 Guanilib 54 include PLX IBD 54 ARRY # 54 HER2 ErbB2 54 ACHN 54 research anddevelopment 54 Oasmia 54 STRENGTHENS ITS 54 ZEVALIN ® 54 ponatinib 54 HyACT 54 Cancidas 54 Shai Novik President 54 sNDA submission 54 Femring ® 54 metastatic hormone refractory 54 MEK inhibitor 54 Solulin 54 Organon Pharmaceuticals 54 personalized cellular immunotherapy 54 HCV polymerase inhibitor 54 Anticalin ® 54 PAION AG 54 OXIGON 54 MOZOBIL 54 Phase IIa trials 54 OMAPRO ™ 54 Zegerid OTC 54 orally dosed 54 pan HDAC inhibitor 54 Drug Eluting Stent System 54 FACTIVE R gemifloxacin 54 tazarotene 54 Orazol 54 GALNS 54 introduced NEUGENE 54 novel peptide 54 Delipidation 54 PhosLo R 54 polymerase inhibitor 54 Sankyo Pharma 54 olmesartan medoxomil hydrochlorothiazide 54 Xenazine ® 54 Liestal Switzerland 54 Cimzia certolizumab pegol 54 NVA# 54 Avila Therapeutics 54 cystinosis patients 54 DPP4 inhibitor 54 Catena ® 54 oral JAK#/JAK# inhibitor 54 MVA HPV IL2 54 Anticalin R 54 Staphylococcus aureus Immune Globulin 54 Pharma AG 54 TH# [003] 54 POTELLIGENT ® 54 Pharmacia Diagnostics 54 PDE# inhibitors 54 reversible inhibitor 54 Onko Sure TM 54 investigational antiplatelet agent 54 Ortho Dermatologics 54 technology visit http:/www.genmab.com 54 dSLIM 54 OTCBB HPLF FWB HL1 54 monoclonal antibody therapeutics 54 novel peptides 54 FavId 54 Cinryze ™ 54 mGluR5 negative 54 Augment ™ 54 Zalbin 54 Dexilant 54 APEX PD 54 initiate Phase 2b 54 partner ECR Pharmaceuticals 54 Gonal f ® 54 selective agonist 54 Copegus ® 54 Scil Proteins 54 torezolid 54 candidate REP# 54 Resurgex R 54 Azedra 54 Nasdaq ONXX 54 IMiDs ® 54 euro adhoc Intercell AG 54 multicenter Phase 54 ENMD # 54 Maribavir 54 INFeD ® 54 Nasdaq IMGN biotechnology 54 MORAb 54 Zenvia Phase III 54 OMNARIS 54 Ozarelix 54 HEPLISAV TM 54 KL4 Surfactant 54 erlotinib Tarceva R 54 StromaCel Inc. 54 InNexus Biotechnology 54 CIP TRAMADOL ER 54 LAF# 54 POTELLIGENT R 54 Cimzia TM 54 BUPHENYL R 54 oral anticancer 54 MAXY VII 54 SBL Vaccines 54 miconazole Lauriad ® 54 Nippon Shinyaku 54 MetroGel 54 AFREZZA TM 54 Phase 2b Trial 54 Inc. Amex SYI 54 Adenosine Therapeutics 54 lomitapide 54 Xyfid TM 54 Risperidone Oral Solution 54 Glufast 54 5 HT2C 54 tezampanel NGX# 54 Restoraderm 54 peptibody 54 Levaquin levofloxacin 54 IV bolus formulation 54 Pancreate 54 Advicor 54 Cutanea 54 Gamunex C 54 glatiramer 54 Kineret ® 54 vascular disrupting agent 54 Plicera 54 ABL inhibitor 54 Infergen R 54 DermTech International 54 Curosurf 54 NicVAX TM 54 Biologic License Application BLA 54 ATL/TV# 54 Teriflunomide 54 CysDisplay 54 Phase #b/#a trial 54 PDE4 54 Allosteric modulation 54 mTOR kinase 54 cannabinor 54 Nautilus Biotech 54 PORxin TM 54 Viprovex R 54 RTP #i 54 M Vax 54 Dermylex ™ 53 Oxytrex TM 53 Octreotide 53 EHT AGN 53 Prandin 53 Nivestim 53 Menarini Group 53 CyDex Pharmaceuticals 53 Omapro 53 Cellegesic 53 commercializing Loramyc ® 53 5 HT2A inverse 53 Reyataz atazanavir 53 tranilast 53 Kosan proprietary 53 oral dihydropyrimidine dehydrogenase DPD 53 nonsedating antihistamine 53 Aranesp darbepoetin alfa 53 ImVisioN 53 selective A2A adenosine receptor 53 Tiazac 53 Convivia TM 53 Aryplase 53 torezolid phosphate 53 Arzerra ofatumumab 53 HuMax CD#b 53 GRAS notification 53 Varespladib 53 Anturol TM 53 Enhanze TM Technology 53 Pruvel TM 53 Glybera R 53 Thrombin topical Recombinant 53 investigational compound 53 Veregen TM 53 IIb clinical trial 53 Curaxin 53 maturation inhibitor 53 SomatoKine 53 OMAPRO 53 small molecule agonists 53 Peyronie disease Frozen Shoulder 53 Alvesco R 53 enoxaparin sodium injection 53 Sufentanil 53 bendamustine HCl 53 Dual Opioid TM 53 tumor xenograft models 53 adenosine A2A 53 Ablynx NV 53 Manja Bouman CEO 53 HDL Mimetic Peptide 53 rhIGF-I/rhIGFBP-3 53 NASDAQ CRXL 53 Ecallantide 53 Vimpat ® lacosamide 53 Perflubutane Polymer Microspheres 53 autologous cellular immunotherapy 53 Synerx Pharma 53 Certican 53 oral methylnaltrexone 53 vemurafenib 53 affinity ligands 53 Cardium Therapeutics TM 53 Loramyc 53 PD LID 53 Nasdaq HALO biopharmaceutical 53 Goserelin 53 preclinical efficacy 53 UCB Cimzia 53 Fortical R 53 ganetespib 53 APTIMA HPV assay 53 Inc. AMEX YMI 53 MP4 molecule 53 investigational pan BCR 53 GTC recombinant form 53 lucinactant 53 VANOS TM 53 FGFR 53 Difimicin 53 RxKinetix 53 PIX# trial 53 Bioral Amphotericin B. 53 pharmacodynamic profile 53 Simulect 53 antisense inhibitor 53 PLK1 SNALP 53 GIPET 53 Skin Cholesterol Test 53 recurrent metastatic ovarian cancer 53 Premarket Approval Application 53 NYSE Amex PTN 53 ERYtech Pharma 53 doxercalciferol 53 Biomed Foods 53 CORT # estimates 53 Vancocin R 53 Novartis VIRT X 53 registrational trial 53 Resurgex Plus 53 JenaValve